Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04281875 · ClinicalTrials.gov registry record · NA
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT04281875 is a NA study that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 160 participants.
The verdict
NCT04281875, a NA study, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study describes a single center, randomized, single-blinded clinical trial to assess the clinical benefits of the use of near infrared autofluorescence (NIRAF) detection with an FDA-cleared device 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx). It compares risk-benefits and outcomes in TTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.
Interventions
- DEVICE NIRAF Detection Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2020-03-16 |
| Est. Completion | 2024-02-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04281875
The ClinicalTrials.gov registry entry for NCT04281875 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIRAF Detection Technology is the first listed.
NCT04281875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04281875 about?
NCT04281875 is a clinical study titled "Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.". This study describes a single center, randomized, single-blinded clinical trial to assess the clinical benefits of the use of near infrared autofluorescence (NIRAF) detection with an FDA-cleared device 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx...
What is the current status of trial NCT04281875?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2020-03-16. Estimated completion is 2024-02-23.
What interventions are being tested in trial NCT04281875?
The interventions under investigation include: NIRAF Detection Technology (DEVICE).
Who is sponsoring clinical trial NCT04281875?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.